(NYSE: DGX) Quest Diagnostics's forecast annual revenue growth rate of 4.52% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.4%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Quest Diagnostics's revenue in 2025 is $10,158,000,000.On average, 9 Wall Street analysts forecast DGX's revenue for 2025 to be $1,202,512,632,945, with the lowest DGX revenue forecast at $1,191,657,311,283, and the highest DGX revenue forecast at $1,207,730,921,448. On average, 9 Wall Street analysts forecast DGX's revenue for 2026 to be $1,248,845,819,244, with the lowest DGX revenue forecast at $1,239,577,953,994, and the highest DGX revenue forecast at $1,261,279,666,479.
In 2027, DGX is forecast to generate $1,294,813,622,643 in revenue, with the lowest revenue forecast at $1,291,220,523,341 and the highest revenue forecast at $1,300,106,706,912.